Prediction of Jaundice in Term Infants

NCT01203410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2019-03-22

No results posted yet for this study

Summary

The objective of this study was to describe total bilirubin production in healthy term infants as a means of understanding the differences in jaundice pigment production associated with various common clinical circumstances.

Conditions

  • Infant, Newborn
  • Jaundice

Sponsors & Collaborators

  • NICHD Neonatal Research Network

    lead NETWORK

Principal Investigators

  • David K. Stevenson, MD · Stanford University

  • William Oh, MD · Brown University, Women & Infants Hospital of Rhode Island

  • Avroy A. Fanaroff, MD · Case Western Reserve University

  • James A. Lemons, MD · Indiana University

  • Raymond Bain, PhD · George Washington University

  • Seetha Shankaran, MD · Wayne State University

  • Jon E. Tyson, MD · University of Texas

  • Sheldon B. Korones, MD · University of Tennessee

  • Charles R. Bauer, MD · University of Miami

  • Barbara J. Stoll, MD · Emory University

  • Lu-Ann Papile, MD · University of New Mexico

  • Edward F. Donovan, MD · Children's Hospital Medical Center, Cincinnati

  • Richard A. Ehrenkranz, MD · Yale University

Eligibility

Max Age
8 Hours
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1991-11-30
Primary Completion
1992-11-30
Completion
1992-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203410 on ClinicalTrials.gov